By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Cleveland Biolabs Inc. 

10265 Carnegie Avenue

Cleveland  Ohio  44106  U.S.A.
Phone: 216-445-0814 Fax: 216-636-3429


SEARCH JOBS



Segment
Start Up





Company News
Cleveland Biolabs Inc. (CBLI) Receives Funding Recommendation From Department Of Defense For Additional Development Proposal For Entolimod (CBLB502) As A Medical Radiation Countermeasure 4/16/2015 2:03:14 PM
Cleveland Biolabs Inc. (CBLI) Announces New U.S. Composition Of Matter Patent For CBLB612 4/2/2015 11:11:52 AM
Cleveland Biolabs Inc. (CBLI) Announces Completion Of Dosing In Phase I Study Of CBLB612 In Russian Federation 3/16/2015 11:26:11 AM
Cleveland Biolabs Inc. (CBLI) And Incuron Announce Growth Of Curaxin CBL0137 Patent Portfolio With U.S. Composition Of Matter Patent 3/3/2015 9:39:42 AM
Cleveland Biolabs Inc. (CBLI) Reports Fourth Quarter And Fiscal 2014 Financial Results And Development Progress 2/24/2015 1:02:23 PM
Cleveland Biolabs Inc. (CBLI) To Report Fourth Quarter And Fiscal Year 2014 Financial Results On February 24 2/20/2015 10:44:20 AM
Cleveland Biolabs Inc. (CBLI) Announces Receipt of Letter From NASDAQ Confirming Compliance With Minimum Bid Price Requirement 2/18/2015 7:51:36 AM
Cleveland Biolabs Inc. (CBLI) Announces Annual Meeting 2/12/2015 12:56:01 PM
Cleveland Biolabs Inc. (CBLI) Announces Expansion of Entolimod Patent Portfolio With New Composition of Matter Patents 2/11/2015 3:14:44 PM
Cleveland Biolabs Inc. (CBLI)To Present At 2015 BIO CEO & Investor Conference 2/5/2015 12:33:23 PM
12345678910...
//-->